Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

2020194 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet Psychiatry

Volume 7, Issue 10, pp. 865-874

Field-Weighted Citation Impact: 18.94